TET2 and angioimmunoblastic T-cell lymphoma: In AITL, in contrast, IDH2R172 mutations are identified almost exclusively in samples that also harbor TET2 mutations [22, 29, 31–33], and cells in those samples generally show markedly increased H3K27me3 levels plus hypermethylation of promoter regions genome wide.